{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:43:32Z","timestamp":1787237012882,"version":"build-2736575974"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,2,25]],"date-time":"2015-02-25T00:00:00Z","timestamp":1424822400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13048-015-0131-9","type":"journal-article","created":{"date-parts":[[2015,2,24]],"date-time":"2015-02-24T07:29:10Z","timestamp":1424762950000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Use of aromatase inhibitors in practice of gynecology"],"prefix":"10.1186","volume":"8","author":[{"given":"Betul","family":"Usluogullari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candan Zehra","family":"Duvan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celil Alper","family":"Usluogullari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,25]]},"reference":[{"key":"131_CR1","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1067\/mjd.2001.117432","volume":"45","author":"LR Nelson","year":"2001","unstructured":"Nelson LR, Bulun SE: Estrogen production and action. J Am Acad Dermatol 2001, 45: 116\u201324. 10.1067\/mjd.2001.117432","journal-title":"J Am Acad Dermatol"},{"key":"131_CR2","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJMra000471","volume":"346","author":"CJ Gruber","year":"2002","unstructured":"Gruber CJ, Tschugguel W, Schneeberger C, Huber JC: Production and Actions of Estrogens. N Engl J Med 2002, 346: 340\u201352. 10.1056\/NEJMra000471","journal-title":"N Engl J Med"},{"key":"131_CR3","doi-asserted-by":"crossref","first-page":"5364","DOI":"10.1016\/S0021-9258(20)79735-8","volume":"249","author":"EA Thompson","year":"1974","unstructured":"Thompson EA, Siiteri PK: Utilization of oxygen and reduced nicotinamide adenine dinucleotide phosphate by human placental microsomes during aromatization of androstenedione. J Biol Chem 1974, 249: 5364\u201372.","journal-title":"J Biol Chem"},{"key":"131_CR4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1089\/dna.1988.7.27","volume":"7","author":"SA Chen","year":"1988","unstructured":"Chen SA, Besman MJ, Sparkes RS, Zollman S, Klisak I, Mohandas T, et al.: Human aromatase: cDNA cloning, Southern blot analysis, and assignment of the gene to chromosome 15. DNA 1988, 7: 27\u201338. 10.1089\/dna.1988.7.27","journal-title":"DNA"},{"key":"131_CR5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1210\/er.2008-0016","volume":"30","author":"RJ Santen","year":"2009","unstructured":"Santen RJ, Brodie H, Simpson ER, Siiteri PK, Brodie A: History of aromatase: saga of an important biological mediator and therapeutic target. Endocr Rev 2009, 30: 343\u201375. 10.1210\/er.2008-0016","journal-title":"Endocr Rev"},{"key":"131_CR6","first-page":"301","volume":"10","author":"DP McDonnell","year":"1999","unstructured":"McDonnell DP: The molecular pharmacology of SERMs Trends Endocrinol. Metab 1999, 10: 301\u201311.","journal-title":"Metab"},{"key":"131_CR7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0960-0760(94)90269-0","volume":"49","author":"AM Brodie","year":"1994","unstructured":"Brodie AM: Aromatase inhibitors in the treatment of breast cancer. J Steroid Biochem Mol Biol 1994, 49: 281\u20137. 10.1016\/0960-0760(94)90269-0","journal-title":"J Steroid Biochem Mol Biol"},{"key":"131_CR8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jsbmb.2011.02.001","volume":"125","author":"S Chumsri","year":"2011","unstructured":"Chumsri S, Howes T, Bao T, Sabnis G, Brodie A: Aromatase, aromatase inhibitors, and breast cancer. J Steroid Biochem Mol Biol 2011, 125: 13\u201322. 10.1016\/j.jsbmb.2011.02.001","journal-title":"J Steroid Biochem Mol Biol"},{"key":"131_CR9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.fertnstert.2005.05.078","volume":"85","author":"H Holzer","year":"2006","unstructured":"Holzer H, Casper R, Tulandi T: A new era in ovulation induction. Fertil Steril 2006, 85: 277\u201384. 10.1016\/j.fertnstert.2005.05.078","journal-title":"Fertil Steril"},{"key":"131_CR10","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/0002-9378(86)90136-5","volume":"155","author":"RP Jansen","year":"1986","unstructured":"Jansen RP: Russell PNonpigmented endometriosis: clinical, laparoscopic, and pathologic definition. Am J Obstet Gynecol 1986, 155: 1154\u20139. 10.1016\/0002-9378(86)90136-5","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"131_CR11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1023\/A:1023048318719","volume":"15","author":"EH Yanushpolsky","year":"1998","unstructured":"Yanushpolsky EH: Effects of endometriomas on ooccyte quality, embryo quality, and pregnancy rates in in vitro fertilization cycles: a prospective, case-controlled study. J Assist Reprod Genet 1998,15(4):193\u20137. 10.1023\/A:1023048318719","journal-title":"J Assist Reprod Genet"},{"issue":"9","key":"131_CR12","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1477-7827-9-88","volume":"21","author":"S Ferrero","year":"2011","unstructured":"Ferrero S: Letrozole and norethisterone acetate versus letrozole and triptorelin in the treatment of endometriosis related pain symptoms: a randomized controlled trial. Reprod Biol Endocrinol 2011,21(9):88. 10.1186\/1477-7827-9-88","journal-title":"Reprod Biol Endocrinol"},{"key":"131_CR13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jsbmb.2005.04.012","volume":"95","author":"SE Bulun","year":"2005","unstructured":"Bulun SE, Imir G, Utsunomiya H, Thung S, Gurates B, Tamura M: Aromatase in endometriosis and uterine leiomyomata. J Steroid Biochem Mol Biol 2005, 95: 57\u201362. 10.1016\/j.jsbmb.2005.04.012","journal-title":"J Steroid Biochem Mol Biol"},{"key":"131_CR14","first-page":"1831","volume":"79","author":"SE Bulun","year":"1994","unstructured":"Bulun SE, Economos K, Miller D: CYP19 (aromatase cytochrome P459) gene expression in human malignant endometrial tumors. J Clin Endocrinol Metab 1994, 79: 1831\u20134.","journal-title":"J Clin Endocrinol Metab"},{"key":"131_CR15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0960-0760(01)00134-0","volume":"79","author":"SA Bulun","year":"2001","unstructured":"Bulun SA, Yang S, Fang Z: Role of aromatase in endometrial disease. J Steroid Biochem Mol Biol 2001, 79: 19\u201325. 10.1016\/S0960-0760(01)00134-0","journal-title":"J Steroid Biochem Mol Biol"},{"key":"131_CR16","first-page":"1209","volume":"4","author":"V Paola","year":"2003","unstructured":"Paola V, Mangioni S, Odorizzi MP, Chiodini A, Rocca S, Chiodo I: Use of estrogen antagonists and aromatase inhibitors in endometriosis. Curr Opin Investig Drugs 2003, 4: 1209\u201312.","journal-title":"Curr Opin Investig Drugs"},{"key":"131_CR17","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.fertnstert.2005.02.018","volume":"84","author":"LL Amsterdam","year":"2005","unstructured":"Amsterdam LL, Gentry W, Jobanputra S, Wolf M, Rubin SD, Bulun SE: Anastrozole and oral contraceptives: a novel treatment for endometriosis. Fertil Steril 2005, 84: 300\u20134. 10.1016\/j.fertnstert.2005.02.018","journal-title":"Fertil Steril"},{"key":"131_CR18","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/humrep\/deh035","volume":"19","author":"S Soysal","year":"2004","unstructured":"Soysal S, Soysal ME, Ozer S, Gul N, Gezgin T: The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial. Hum Reprod 2004, 19: 160\u20137. 10.1093\/humrep\/deh035","journal-title":"Hum Reprod"},{"issue":"2","key":"131_CR19","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.fertnstert.2003.09.029","volume":"81","author":"R Ailawadi","year":"2004","unstructured":"Ailawadi R, Jobanputra S, Kataria M, Gurates B, Bulun S: Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study. Fertil Steril 2004,81(2):290\u20136. 10.1016\/j.fertnstert.2003.09.029","journal-title":"Fertil Steril"},{"key":"131_CR20","first-page":"291e15","volume":"95","author":"SS Lall","year":"2010","unstructured":"Lall SS, Kamilya G, Mukherji J, De A, Ghosh D, Majhi AK: Aromatase inhibitors in recurrent ovarian endometriomas: report of five cases with literature review. Fertil Steril 2010, 95: 291e15\u20138.","journal-title":"Fertil Steril"},{"issue":"6","key":"131_CR21","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1097\/01.AOG.0000265807.19397.6d","volume":"109","author":"NA Mousa","year":"2007","unstructured":"Mousa NA, Bedaiwy MA, Casper RF: Aromatase inhibitors in the treatment of severe endometriosis. Obstet Gynecol 2007,109(6):1421\u20133. 10.1097\/01.AOG.0000265807.19397.6d","journal-title":"Obstet Gynecol"},{"key":"131_CR22","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1471-0528.2008.01740.x","volume":"115","author":"S Patwardhan","year":"2008","unstructured":"Patwardhan S, Nawathe A, Yates D, Harrison GR, Khan KS: Systematic review of the effects of aromatase inhibitors on pain associated with endometriosis. BJOG 2008, 115: 818\u201322. 10.1111\/j.1471-0528.2008.01740.x","journal-title":"BJOG"},{"key":"131_CR23","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.fertnstert.2011.07.1136","volume":"96","author":"F Abushahin","year":"2011","unstructured":"Abushahin F, Goldman KN, Barbieri E: Aromatase inhibition for refractory endometriosis-related chronic pelvic pain. Fertil Steril 2011, 96: 939\u201342. 10.1016\/j.fertnstert.2011.07.1136","journal-title":"Fertil Steril"},{"key":"131_CR24","first-page":"736","volume":"78","author":"SE Bulun","year":"1994","unstructured":"Bulun SE, Simpson ER, Word RA: Expression of the CYP19 gene and its product aromatase cytochrome P450 in human uterine leiomyoma tissues and cells in culture. J Clin Endocrinol Metab 1994, 78: 736.","journal-title":"J Clin Endocrinol Metab"},{"key":"131_CR25","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1210\/jcem.87.6.8533","volume":"87","author":"M Shozu","year":"2002","unstructured":"Shozu M, Sumitani H, Segawa T, Yang HJ, Murakami K, Kasai T: Over-expression of aromatase P-450 in leiomyoma tissues is driven through the promoter I.4 of aromatase P-450. J Clin Endocrinol Metab 2002, 87: 2540\u20138. 10.1210\/jcem.87.6.8533","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"131_CR26","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/01.AOG.0000279151.20878.60","volume":"110","author":"FK Varelas","year":"2007","unstructured":"Varelas FK, Papanicolaou AN, Vavatsi-Christaki N, Makedos GA, Vlassis GD: The effect of anastrazole on symptomatic uterine leiomyomata. Obstet Gynecol 2007,110(3):643. 10.1097\/01.AOG.0000279151.20878.60","journal-title":"Obstet Gynecol"},{"key":"131_CR27","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.fertnstert.2007.11.006","volume":"91","author":"SG Hilario","year":"2009","unstructured":"Hilario SG, Bozzini N, Borsari R, Baracat EC: Action of aromatase inhibitor for treatment of uterine leiomyoma in perimenopausal patients. Fertil Steril 2009, 91: 240\u20133. 10.1016\/j.fertnstert.2007.11.006","journal-title":"Fertil Steril"},{"key":"131_CR28","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2165\/00002018-199921040-00005","volume":"21","author":"LB Michaud","year":"1999","unstructured":"Michaud LB, Buzdar AU: Risks and benefits of aromatase inhibitors in postmenopausal breast cancer. Drug Saf 1999, 21: 297\u2013309. 10.2165\/00002018-199921040-00005","journal-title":"Drug Saf"},{"key":"131_CR29","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.fertnstert.2008.09.064","volume":"93","author":"ME Parsanezhad","year":"2010","unstructured":"Parsanezhad ME, Azmoon M, Alborzi S: A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status. Fertil Steril 2010, 93: 192\u20138. 10.1016\/j.fertnstert.2008.09.064","journal-title":"Fertil Steril"},{"key":"131_CR30","first-page":"247","volume":"42","author":"LM Hansen","year":"1997","unstructured":"Hansen LM, Batzer FR, Corson SL, Bello S: Obesity and GnRH action. Report of a case with contribution by peripherally derived estrogens. J Reprod Med 1997, 42: 247\u201350.","journal-title":"J Reprod Med"},{"key":"131_CR31","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/CCO.0b013e3281a7ef3a","volume":"19","author":"O Reich","year":"2007","unstructured":"Reich O, Regauer S: Hormonal therapy of endometrial stromal sarcoma. Curr Opin Oncol 2007, 19: 347. 10.1097\/CCO.0b013e3281a7ef3a","journal-title":"Curr Opin Oncol"},{"key":"131_CR32","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijgo.2007.06.041","volume":"100","author":"H Li","year":"2008","unstructured":"Li H, Chen X, Qiao J: Letrozole as primary therapy for endometrial hyperplasia in young women. \u0130nt J of Gynecol Obst 2008, 100: 10\u20132. 10.1016\/j.ijgo.2007.06.041","journal-title":"\u0130nt J of Gynecol Obst"},{"key":"131_CR33","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1048-891X.2004.14419.x","volume":"14","author":"BB Ma","year":"2004","unstructured":"Ma BB, Oza A, Eisenhauer E: The activity of letrozole in patients with advanced or recurrent endometrial cancer and correlation with biological markers\u2013a study of the National Cancer Institute of Canada Clinical Trials Group. Int J Gynecol Cancer 2004, 14: 650. 10.1111\/j.1048-891X.2004.14419.x","journal-title":"Int J Gynecol Cancer"},{"key":"131_CR34","doi-asserted-by":"crossref","first-page":"266s","DOI":"10.1200\/jco.2006.24.18_suppl.5042","volume":"24","author":"B Nordstrom","year":"2006","unstructured":"Nordstrom B, Salmi T, Mirza M: Exemestane in advanced and recurrent endometrial carcinoma: a phase II trial (abstract). J Clin Onc 2006, 24: 266s.","journal-title":"J Clin Onc"},{"key":"131_CR35","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0959-8049(00)00228-8","volume":"36","author":"C Trope","year":"2000","unstructured":"Trope C, Marth C, Kaern J: Tamoxifen in the treatment of recurrent ovarian carcinoma. Eur J Cancer 2000, 36: 59\u201361. 10.1016\/S0959-8049(00)00228-8","journal-title":"Eur J Cancer"},{"key":"131_CR36","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1525-1438.2007.01075.x","volume":"18","author":"YF Li","year":"2008","unstructured":"Li YF, Hu W, Fu JDI: Aromatase inhibitors in ovarian cancer: is there a role? Int J Gynecol Cancer 2008, 18: 600\u201314. 10.1111\/j.1525-1438.2007.01075.x","journal-title":"Int J Gynecol Cancer"},{"issue":"6510","key":"131_CR37","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1136\/bmj.291.6510.1693","volume":"291","author":"MG Hull","year":"1985","unstructured":"Hull MG, Glazener CM, Kelly NJ, Conway DI, Foster PA, Hinton RA, et al.: Population study of causes, treatment, and outcome of infertility. Br Med J (Clin Res Ed) 1985,291(6510):1693. 10.1136\/bmj.291.6510.1693","journal-title":"Br Med J (Clin Res Ed)"},{"key":"131_CR38","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1479-828X.2001.tb01296.x","volume":"41","author":"G Kovacs","year":"2001","unstructured":"Kovacs G, Wood C: The current status of polycystic ovary syndrome. Aust NZ J Obstet Gynecol 2001, 41: 65\u20138. 10.1111\/j.1479-828X.2001.tb01296.x","journal-title":"Aust NZ J Obstet Gynecol"},{"key":"131_CR39","first-page":"189","volume":"83","author":"MR Fluker","year":"1994","unstructured":"Fluker MR, Urman B, Mackinnon M, Barrow SR, Pride SM, Yuen BH: Exogenous gonadotropin therapy in World Health Organization groups I and II ovulatory disorders. Obstet Gynecol 1994, 83: 189\u201396.","journal-title":"Obstet Gynecol"},{"key":"131_CR40","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ajog.2004.08.013","volume":"192","author":"MF Mitwally","year":"2005","unstructured":"Mitwally MF, Biljan MM, Casper RF: Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation. Am J Obstet Gynecol 2005, 192: 381\u20136. 10.1016\/j.ajog.2004.08.013","journal-title":"Am J Obstet Gynecol"},{"key":"131_CR41","first-page":"773","volume":"18","author":"R Homburg","year":"2004","unstructured":"Homburg R: Management of infertility and prevention of ovarian hyperstimulation in women with polycystic ovary syndrome. Clin Obstet Gynecol 2004, 18: 773\u20138.","journal-title":"Clin Obstet Gynecol"},{"key":"131_CR42","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1093\/humrep\/14.11.2700","volume":"14","author":"MF Mitwally","year":"1999","unstructured":"Mitwally MF, Kuscu NK, Yalcinkaya TM: High ovulatory rates in case of troglitazone in clomiphene-resistant women with polycystic ovary syndrome. Hum Reprod 1999, 14: 2700\u20133. 10.1093\/humrep\/14.11.2700","journal-title":"Hum Reprod"},{"issue":"6","key":"131_CR43","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/humupd\/dmn033","volume":"14","author":"A Requena","year":"2008","unstructured":"Requena A, Herrero J, Landeras J, Salvador C, Tur R, Callejo J, et al.: Use of letrozole in assisted reproduction: a systematic review and meta-analysis. Hum Reprod Update 2008,14(6):571\u201382. 10.1093\/humupd\/dmn033","journal-title":"Hum Reprod Update"},{"issue":"3","key":"131_CR44","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1210\/jc.2005-1923","volume":"91","author":"RF Casper","year":"2006","unstructured":"Casper RF: Mitwally MF Review: aromatase inhibitors for ovulation induction. J Clin Endocrinol Metab 2006,91(3):760\u201371. 10.1210\/jc.2005-1923","journal-title":"J Clin Endocrinol Metab"},{"key":"131_CR45","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0015-0282(00)01705-2","volume":"75","author":"MF Mitwally","year":"2001","unstructured":"Mitwally MF, Casper RF: Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril 2001, 75: 305\u20139. 10.1016\/S0015-0282(00)01705-2","journal-title":"Fertil Steril"},{"key":"131_CR46","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/14647270701689670","volume":"11","author":"R Homburg","year":"2008","unstructured":"Homburg R: Oral agents for ovulation induction\u2014clomiphene citrate versus aromatase inhibitors. Hum Fertil (Camb) 2008, 11: 17\u201322. 10.1080\/14647270701689670","journal-title":"Hum Fertil (Camb)"},{"key":"131_CR47","doi-asserted-by":"crossref","unstructured":"Franik S, Kremer JAM, Nelen WLDM, Farquhar C. Aromatase inhibitors for subfertile women with polycystic ovary syndrome. Cochrane Database of Syst Rev 2014, Issue 2. Art. No: CD010287.","DOI":"10.1002\/14651858.CD010287.pub2"},{"issue":"3","key":"131_CR48","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/humupd\/dms003","volume":"18","author":"ML Misso","year":"2012","unstructured":"Misso ML, Wong JL, Teede HJ, Hart R, Rombauts L, Melder AM, et al.: Aromatase inhibitors for PCOS: a systematic review and meta-analysis. Hum Reprod Update 2012,18(3):301\u201312. 10.1093\/humupd\/dms003","journal-title":"Hum Reprod Update"},{"key":"131_CR49","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijgo.2010.11.026","volume":"3","author":"MS Abdellah","year":"2011","unstructured":"Abdellah MS: Reproductive outcome after letrozole versus laparoscopic ovarian drilling for clomiphene-resistant polycystic ovary syndrome. Int J Gynaecol Obstet 2011, 3: 218\u201321. 10.1016\/j.ijgo.2010.11.026","journal-title":"Int J Gynaecol Obstet"},{"key":"131_CR50","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0015-0282(16)56043-9","volume":"60","author":"OG Naether","year":"1993","unstructured":"Naether OG, Fischer R: Adhesion formation after laparoscopic electrocoagulation of the ovarian surface in polycystic ovary patients. Fertil Steril 1993, 60: 95\u20138.","journal-title":"Fertil Steril"},{"key":"131_CR51","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.fertnstert.2011.08.002","volume":"96","author":"K Katherine","year":"2011","unstructured":"Katherine K, McKnight MD, James L: Body mass index\u2013associated differences in response to ovulation induction with letrozole. Fertil Steril 2011, 96: 1206\u20138. 10.1016\/j.fertnstert.2011.08.002","journal-title":"Fertil Steril"},{"key":"131_CR52","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1477-7827-9-84","volume":"9","author":"MF Usama","year":"2011","unstructured":"Usama MF, Ahmed MS: Extended letrozole regimen versus clomiphene citrate for superovulation in patients with unexplained infertility undergoing intrauterine insemination: a randomized controlled trial. Reprod Biol Endocrinol 2011, 9: 84. 10.1186\/1477-7827-9-84","journal-title":"Reprod Biol Endocrinol"},{"key":"131_CR53","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S1472-6483(10)60617-7","volume":"13","author":"A Baysoy","year":"2006","unstructured":"Baysoy A, Serdaroglu H, Jamal H: Letrozole versus human menopausal gonadotrophin in women undergoing intrauterine insemination. Reprod BioMed Online 2006, 13: 208\u201312. 10.1016\/S1472-6483(10)60617-7","journal-title":"Reprod BioMed Online"},{"key":"131_CR54","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1016\/j.fertnstert.2008.03.020","volume":"91","author":"MA Bedaiwy","year":"2009","unstructured":"Bedaiwy MA, Shokry M, Mousa N, Claessens A, Esfandiari N, Botleib L, et al.: Letrozole co-treatment in infertile women 40\u00a0years old and older receiving controlled ovarian stimulation and intrauterine insemination. Fertil Steril 2009, 91: 2501\u20137. 10.1016\/j.fertnstert.2008.03.020","journal-title":"Fertil Steril"},{"key":"131_CR55","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/s-2004-823028","volume":"22","author":"M Mitwally","year":"2004","unstructured":"Mitwally M, Casper R: Aromatase inhibitors in ovulation induction. Semin Reprod Med 2004, 22: 61\u201378. 10.1055\/s-2004-823028","journal-title":"Semin Reprod Med"},{"key":"131_CR56","first-page":"1641","volume":"13","author":"LC Giudice","year":"1992","unstructured":"Giudice LC: Insulin-like growth factors and ovarian follicular development. Endocr Rev 1992, 13: 1641\u201369.","journal-title":"Endocr Rev"},{"key":"131_CR57","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jsgi.2004.03.006","volume":"11","author":"M Mitwally","year":"2004","unstructured":"Mitwally M, Casper R: Aromatase inhibition reduces the dose of gonadotropin required for controlled ovarian hyperstimulation. J Soc Gynecol Investig 2004, 11: 406\u201315. 10.1016\/j.jsgi.2004.03.006","journal-title":"J Soc Gynecol Investig"},{"issue":"Suppl 2","key":"131_CR58","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.fertnstert.2004.07.007","volume":"82","author":"K Oktay","year":"2004","unstructured":"Oktay K, Buyuk E, Akar M, Rosenwaks Z, Libertella N: Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation [abstract]. Fertil Steril 2004,82(Suppl 2):S1. 10.1016\/j.fertnstert.2004.07.007","journal-title":"Fertil Steril"},{"key":"131_CR59","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/humrep\/deh359","volume":"19","author":"SK Goswami","year":"2004","unstructured":"Goswami SK, Das T, Chattopadhyay R, Sawhney J, Kumar J, Chaudhury K: A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report. Hum Reprod 2004, 19: 2031\u20135. 10.1093\/humrep\/deh359","journal-title":"Hum Reprod"},{"key":"131_CR60","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.fertnstert.2005.01.117","volume":"84","author":"JA Garcia-Velasco","year":"2005","unstructured":"Garcia-Velasco JA, Moreno L, Pacheco A: The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study. Fertil Steril 2005, 84: 82\u20137. 10.1016\/j.fertnstert.2005.01.117","journal-title":"Fertil Steril"},{"key":"131_CR61","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejogrb.2009.02.001","volume":"144","author":"K Lossl","year":"2009","unstructured":"Lossl K, Loft A, Freiesleben NLC, Andersen CY, Pedersen AT, et al.: Bangsb\u03c6ll: Combined down-regulation by aromatase inhibitor and GnRH-agonist in IVF patients with endometriosis - A pilot study. Eur J Obstet Gynecol Reprod Biol 2009, 144: 48\u201353. 10.1016\/j.ejogrb.2009.02.001","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"131_CR62","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1472-6483(10)61046-2","volume":"14","author":"A Badawy","year":"2007","unstructured":"Badawy A, Metwally M, Fawzy M: Randomized controlled trail of three doses of letrozole for ovulation induction in patients with unexplained infertility. Reprod Biomed Online 2007, 14: 559\u201362. 10.1016\/S1472-6483(10)61046-2","journal-title":"Reprod Biomed Online"},{"issue":"(Suppl. 1","key":"131_CR63","first-page":"0","volume":"84","author":"MM Biljan","year":"2005","unstructured":"Biljan MM, Hemmings R, Brassard N: The outcome of 150 babies following the treatment with letrozole or letrozole and gonadotropins. Fertil Steril 2005,84((Suppl. 1):0\u2013231. Abstract 1033","journal-title":"Fertil Steril"},{"key":"131_CR64","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.fertnstert.2006.03.014","volume":"85","author":"T Tulandi","year":"2006","unstructured":"Tulandi T, Martin J, Al-Fadhli R: Congenital malformations among 911 newborns conceived after infertility treatment with letrazole or clomiphene citrate. Fertil Steril 2006, 85: 1761. 10.1016\/j.fertnstert.2006.03.014","journal-title":"Fertil Steril"},{"issue":"3","key":"131_CR65","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.fertnstert.2007.03.094","volume":"92","author":"RF Casper","year":"2009","unstructured":"Casper RF: Letrazole versus clomiphene citrate: which is beter for ovulation induction? Fertil Steril 2009,92(3):858\u20139. 10.1016\/j.fertnstert.2007.03.094","journal-title":"Fertil Steril"},{"key":"131_CR66","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.fertnstert.2004.07.952","volume":"83","author":"M Mitwally","year":"2005","unstructured":"Mitwally M, Casper R: Single-dose administration of an aromatase inhibitor for ovarian stimulation. Fertil Steril 2005, 83: 229. 10.1016\/j.fertnstert.2004.07.952","journal-title":"Fertil Steril"},{"key":"131_CR67","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1200\/JCO.2002.06.020","volume":"20","author":"EP Winer","year":"2002","unstructured":"Winer EP, Hudis C, Burstein HJ: American Society of Clinical Oncology techology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report. J Clin Oncol 2002, 20: 3317. 10.1200\/JCO.2002.06.020","journal-title":"J Clin Oncol"},{"key":"131_CR68","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/annonc\/mdn164","volume":"19","author":"P Hadji","year":"2008","unstructured":"Hadji P, Aapro M, Brufsky A: Practical guidance for the prevention of aromatase inhibitor-associated bone loss in women with breast cancer. Ann Oncol 2008, 19: 1407\u201316. 10.1093\/annonc\/mdn164","journal-title":"Ann Oncol"},{"key":"131_CR69","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1470-2045(06)70767-7","volume":"7","author":"A Buzdar","year":"2006","unstructured":"Buzdar A, Howell A, Cuzick J, Wale C, Distler W, et al.: Tamoxifen Arimidex Alone or in Combination Trialists\u2019 Group: Comprehensive side-eff ect profi le of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial. Lancet Oncol 2006, 7: 633\u201343. 10.1016\/S1470-2045(06)70767-7","journal-title":"Lancet Oncol"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-015-0131-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13048-015-0131-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-015-0131-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T12:04:20Z","timestamp":1651320260000},"score":1,"resource":{"primary":{"URL":"http:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-015-0131-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,25]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["131"],"URL":"https:\/\/doi.org\/10.1186\/s13048-015-0131-9","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,25]]},"article-number":"4"}}